Literature DB >> 29715059

Human papillomavirus vaccination and the role of herd effects in future cancer control planning: a review.

Talía Malagón1, Cassandra Laurie1, Eduardo L Franco1.   

Abstract

INTRODUCTION: Vaccine herd effects are the indirect protection that vaccinated persons provide to those who remain susceptible to infection, due to the reduced transmission of infections. Herd effects have been an important part of the discourse on how to best implement human papillomavirus (HPV) vaccines and prevent HPV-related diseases. AREAS COVERED: In this paper, we review the theory of HPV vaccine herd effects derived from mathematical models, give an account of observed HPV vaccine herd effects worldwide, and examine the implications of vaccine herd effects for future cervical cancer screening efforts. EXPERT COMMENTARY: HPV vaccine herd effects improve the cost-effectiveness of vaccinating preadolescent girls, but contribute to making gender-neutral vaccination less economically efficient. Vaccination coverage and sexual mixing patterns by age are strong determinants of herd effects. Many countries worldwide are starting to observe reductions in HPV-related outcomes likely attributable to herd effects, most notably declining anogenital warts in young men, and declining HPV-16/18 infection prevalence in young unvaccinated women. Policy makers making recommendations for cervical cancer screening will have to consider HPV vaccination coverage and herd effects, as these will affect the positive predictive value of screening and the risk of cervical cancer in unvaccinated women.

Entities:  

Keywords:  Anogenital warts; HPV infection; effectiveness; herd effects; herd immunity; human papillomavirus; vaccination; vaccine

Mesh:

Substances:

Year:  2018        PMID: 29715059     DOI: 10.1080/14760584.2018.1471986

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  6 in total

1.  Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women.

Authors:  Chelse Spinner; Lili Ding; David I Bernstein; Darron R Brown; Eduardo L Franco; Courtney Covert; Jessica A Kahn
Journal:  Pediatrics       Date:  2019-01-22       Impact factor: 7.124

2.  Vaccination of Young Women Decreases Human Papillomavirus Transmission in Heterosexual Couples: Findings from the HITCH Cohort Study.

Authors:  Michel D Wissing; Ann N Burchell; Mariam El-Zein; Pierre-Paul Tellier; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-09-05       Impact factor: 4.254

3.  Risk Factors for Non-Human Papillomavirus (HPV) Type 16/18 Cervical Infections and Associated Lesions Among HPV DNA-Negative Women Vaccinated Against HPV-16/18 in the Costa Rica Vaccine Trial.

Authors:  Mónica S Sierra; Sabrina H Tsang; Shangying Hu; Carolina Porras; Rolando Herrero; Aimée R Kreimer; John Schussler; Joseph Boland; Sarah Wagner; Bernal Cortes; Ana C Rodríguez; Wim Quint; Leen-Jan van Doorn; Mark Schiffman; Joshua N Sampson; Allan Hildesheim
Journal:  J Infect Dis       Date:  2021-08-02       Impact factor: 5.226

4.  The Prevalence of HPV Genotypes in Iranian Population: An Update.

Authors:  Mina Mobini Kesheh; Hossein Keyvani
Journal:  Iran J Pathol       Date:  2019

5.  Importance of human papillomavirus infection in squamous cell carcinomas of the tongue in Guangdong Province, China.

Authors:  Kunsong Huang; Guoying Ni; Bowei Ma; Shu Chen; Yi Luan; Tianfang Wang; Shelley Walton; Ian Frazer; Xiaosong Liu; Xuan Pan
Journal:  J Int Med Res       Date:  2020-01       Impact factor: 1.671

6.  Population Impact of Girls-Only Human Papillomavirus 16/18 Vaccination in The Netherlands: Cross-Protective and Second-Order Herd Effects.

Authors:  Joske Hoes; Petra J Woestenberg; Johannes A Bogaards; Audrey J King; Hester E de Melker; Johannes Berkhof; Christian J P A Hoebe; Marianne A B van der Sande; Birgit H B van Benthem
Journal:  Clin Infect Dis       Date:  2021-03-01       Impact factor: 9.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.